Best 2-Decade Total Return Stocks
« Back to slide 1
Continue to slide 3 »

#9. Edwards Lifesciences Corp (EW) — $10K BECAME $540,027.73

Company Name:  Edwards Lifesciences Corp
Sector:  Medical Instruments & Supplies
Growth of $10,000.00
Without Dividends Reinvested Into EW

Edwards Lifesciences is engaged in patient-focused medical for structural heart disease, as well as critical care and surgical monitoring. Co. is a manufacturer of heart valve systems and repair products used to replace or repair a patient's diseased or defective heart valve. Co. is also engaged in hemodynamic and noninvasive brain and tissue oxygenation monitoring systems used to measure a patient's cardiovascular function in the hospital setting. Co.'s products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care.

« Back to slide 1
Continue to slide 3 »
EW 20-Year Return
Start date: 04/04/2000
End date: 04/03/2020
Start price/share: $3.50
End price/share: $189.07
Dividends collected/share: $0.00
Total return: 5,302.00%
Average Annual Total Return: 22.06%
Starting investment: $10,000.00
Ending investment: $540,027.73
Years: 20.01

Presented with the assumption of reinvestment of any dividends on ex-date; historical stock values are shown adjusted for any subsequent splits.
Investing Slideshows
Wise & Famous Investing Quotes
20 Largest Companies In The USA
21 Growth Stocks For 2021
10 Dividend Leaders Ready To Run
Best 5-Year Total Return Stocks
Best 10-Year Total Return Stocks
Best 2-Decade Total Return Stocks
EW — Current Quote
Quotes delayed 20 minutes
Get Free SEC filing alerts for EW:
EW SEC Filing Email Alerts ServiceExternal link
 

Best 2-Decade Total Return Stocks - Page 2 | www.RediNews.com | Copyright © 2013 - 2020, All Rights Reserved

Nothing in RediNews.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video.